Relationship between vitamin D and rheumatoid arthritis disease

Pakistan Journal of Nutrition

Volumn 11, Issue 3, 2012, Pages 293-300

  Azzeh, Firas Sultan ^a  

^a UMM AL QURA UNIVERSITY   (Saudi Arabia)

Author keywords

Rheumatoid arthritis; Vitamin D; Vitamin D receptors (VDR)

Indexed keywords

25 HYDROXYVITAMIN D; ANALGESIC AGENT; ANTIINFLAMMATORY AGENT; ANTIRHEUMATIC AGENT; DIPROQUALONE; DISEASE MODIFYING ANTIRHEUMATIC DRUG; GLUCOCORTICOID; LIDOCAINE; METHOTREXATE; NONSTEROID ANTIINFLAMMATORY AGENT; OPIATE DERIVATIVE; PARACETAMOL; RHEUMATOID FACTOR; UNCLASSIFIED DRUG; VITAMIN D;

ARTHRALGIA; DIAGNOSTIC PROCEDURE; DIETARY INTAKE; DISEASE ACTIVITY; DISEASE ASSOCIATION; DISEASE CLASSIFICATION; HUMAN; PATHOPHYSIOLOGY; REVIEW; RHEUMATOID ARTHRITIS; RISK ASSESSMENT; VITAMIN BLOOD LEVEL; VITAMIN D DEFICIENCY;

EID: 84857892025     PISSN: 16805194     EISSN: None     Source Type: Journal    
DOI: 10.3923/pjn.2012.293.300     Document Type: Review

References (66)

1. ACR (American College of Rheumatology), 2010. Retrieved from http://hosted.ap.org/dynamic/stories/U/US_MED_ARTHRITIS_TOLL?SITE=OHRAV&SECTION=HOME&TEMPLATE=DEFAULT.
2. Adam, O., C. Beringer, T. Kless, C. Lemmen, A. Adam, M. Wiseman, P. Adam, R. Klimmek and W. Forth, 2003. Anti-inflammatory effects of low arachidonic acid diet and fish oil in patients with rheumatoid arthritis. Rheum Inter., 23: 27-36.
3. Aletaha, D., T. Neogi and A. Silman, 2010. 2010 Rheumatoid arthritis classification criteria. An American College of Rheumatology/European League Against Rheumatism Collaborative Initiative. Arth. Rheum., 62: 2569-2581.
4. Alvarez-Lafuente, R., B. Fernandez-Gutierrez, S. de Miguel, J. Jover, R. Rollin, E. Loza, D. Clemente and J. Lamas, 2005. Potential relationship between herpes viruses and rheumatoid arthritis: Analysis with quantitative real time polymerase chain reaction. Anna. Rheum. Dis., 64: 1357-1359.
5. American Association for Clinical Chemistry, 2004. Lab Tests Online for Antinuclear Antibody (ANA). Retrieved from: http://www.labtestsonline.org/understanding/analytes/ana/test.html.
6. American Association for Clinical Chemistry, 2005. Lab Tests Online for Cyclic Citrullinated Peptide antibody (CCP). Retrieved from: http://www.labtestsonline.org/understanding/analytes/ccp/test.html.
7. American Association for Clinical Chemistry, 2006. Lab Tests Online for Rheumatoid Factor (RF). Retrieved from: http://www.labtestsonline.org/understanding/analytes/rheumatoid/test.html.
8. Arnett, F., S. Edworthy, D. Bloch, D. McShane, J. Fries, N. Cooper, L. Healey, S. Kaplan, M. Liang and H. Luthra, 1981. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arth. Rheu., 31: 315-324.
9. Arnson, Y., H. Amital and Y. Shoenfeld, 2007. Vitamin D and autoimmunity: New etiological and therapeutical considerations. Anna. Rheum. Dis., 66: 1137-1142.
10. Balandraud, N. and R. Roudier, 2004. Epstein-Barr virus and rheumatoid arthritis. Autoimm. Rev., 3: 362-367.
11. Boonstra, A., F.J. Barrat, C. Crain, V.L. Heath, H.F. Savelkoul and A. O'Garra, 2001. 1alpha,25- Dihydroxyvitamin d3 has a direct effect on naive CD4 (+) T cells to enhance the development of Th2 cells. J. Immu., 167: 4974-4980.
12. Canter, P., B. Wider and E. Ernst, 2007. The antioxidant vitamins A, C, E and selenium in the treatment of arthritis: A systematic review of randomized clinical trials. Rheumatology, 46: 1223-1233.
13. Canter, P.H., H.S. Lee and E.A. Ernst, 2006. Systematic review of randomised clinical trials of Tripterygium wilfordii for rheumatoid arthritis. Phytomedicine, 13: 371-377.
14. Catalano, M., D. Carson, S. Slovin, D. Richman and H. John Vaughan, 1979. Antibodies to Epstein-Barr virus-determined antigens in normal subjects and in patients with seropositive rheumatoid arthritis. Proceedings of the National Academy of Sciences (USA), Immunology, 76: 5825-5828.
15. Chatfield, S.M., C. Brand, P.R. Ebeling and M. Russell, 2007. Vitamin D deficiency in general medical in patients in summer and winter. Intern. Med. J., 37: 377-382.
16. Choy, E. and G. Panayi, 2001. Cytokine pathways and joint inflammation in rheumatoid arthritis. The New Eng. J. Med., 344: 907-916.
17. Cleland, L.G., M.J. James and S.M. Proudman, 2003. The role of fish oils in the treatment of rheumatoid arthritis. Drugs, 63: 845-853.
18. Combs, G.F., 1988. The Vitamins: Fundamental Aspects in Nutrition and Health, 2nd Edn., New York: Academic Press, pp: 155-182.
19. Cutolo, M., K. Otsa, K. Laas, M. Yprus, R. Lehtme, M.E. Secchi, A. Sulli, S. Paolino and B. Seriolo, 2006. Circannual vitamin d serum levels and disease activity in rheumatoid arthritis: Northern versus Southern Europe. Clin. Exp. Rheumatol., 24: 702-704.
20. Deluca, H.F. and M.T. Cantorna, 2001. Vitamin D: Its role and uses in immunology. FASEB J., 15: 2579-2585.
21. Edwards, J., G. Cambridge and V. Abrahams, 1999. Do self-perpetuating B lymphocytes drive human autoimmune disease? Immunology, 97: 188-196.
22. Ferrell, P., C. Aitcheson, G. Pearson and E. Tan, 1981. Seroepidemiological study of relationships between Epstein-Barr virus and rheumatoid arthritis. J. Clin. Inves., 67: 681-687.
23. Fritsche, J., K. Mondal, A. Ehrnsperger R. and M. Kreutz, 2003. Regulation of 25-hydroxyvitamin D3-1 alpha- hydroxylase and production of 1 alpha 25- dihydroxyvitamin D3 by human dendritic cells. Blood, 102: 3314-3316.
24. Funk, J.L., J.B. Frye and J.N. Oyarzo, 2006. Efficacy and mechanism of action of turmeric supplements in the treatment of experimental arthritis. Arth and Rheu., 54: 3452-3464.
25. Garcia-Lozano, J.R., M.F. Gonzalez-Escribano, A. Valenzuela, A. Garcia and A. Nunez-Roldan, 2001. Association of vitamin D receptor genotypes with early onset rheumatoid arthritis. Int. J. Immun., 28: 89-93.
26. Griffin, M.D., W. Lutz, V.A. Phan, L.A. Bachman, D.J. McKean and R. Kumar, 2001. Dendritic cell modulation by 1alpha, 25 dihydroxyvitamin D3 and its analogs: A vitamin D receptor-dependent pathway that promotes a persistent state of immaturity in vitro and in vivo. The Proc. Natl. Acad. Sci. Online (US), 98: 6800-6805.
27. Griffin, M.D., W.H. Lutz, V.A. Phan, L.A. Bachman, D.J. McKean and R. Kumar, 2000. Potent inhibition of dendritic cell differentiation and maturation by vitamin D analogs. Biochem. Biophsy. Res. Commun., 270: 701-708.
28. Hasler, P., 2006. Biological therapies directed against cells in autoimmune disease. Springer Seminars in Immunopathol., 27: 443-456.
29. Helming, L., J. Bose, J. Ehrchen, S. Schiebe, T. Frahm, R. Geffers, M. Probst-Kepper, R. Balling and A. Lengeling, 2005. 1alpha, 25-Dihydroxyvitamin D3 is a potent suppressor of interferon gamma-mediated macrophage activation. Blood, 106: 4351-4358.
30. Holick, M.F., 2006. Vitamin D. In: Shils, M.E. (Ed), Modern Nutrition in Health and Disease, 10th Edn., Philadelphia: Libbincott Williams and Wilkins, pp: 377-393.
31. Holick, M.F., 2007. Vitamin D deficiency. New. Eng. J. Med., 357: 266-281.
32. Hypponen, E., E. Laara, A. Reunanen, M. Jarvelin and S. Virtanen, 2001. Intake of vitamin D and risk of type 1 diabetes: A birth cohort study. Lancet, 358: 1500-1503.
33. Kamen, D.L., G.S. Cooper, H. Bouali, S.R. Shaftman, B.W. Hollis and G.S. Gilkeson, 2006. Vitamin D deficiency in systemic lupus erythematosus. Autoimmun. Rev., 5: 114-117.
34. Landre-Beauvais, A., 2001. The first description of rheumatoid arthritis. Unabridged text of the doctoral dissertation presented in 1800. Joint Bone Spine, 68: 130-143.
35. Langub, M.C., T.A. Reinhardt, R.L. Horst, H.H. Malluche and N.J. Koszewski, 2000. Characterization of vitamin D receptor immunoreactivity in human bone cells. Bone, 27: 383-387.
36. Lantz, R.C., G.J. Chen, M.A.M. Sarihan, Solyom, S. D. Jolad and B.N. Timmermann, 2007. The effect of extracts from ginger rhizome on inflammatory mediator production. Phytomedicine, 14: 123-128.
37. Leanne, M.W., I. Gaboury, M. Ladhani and S. Zlotkin, 2007. Vitamin D deficiency rickets among children in Canada. Can. Med. Asso. J., 177: 161-166.
38. Lee, R., 2007. Diseases of musculoskeletal system. In: Nelms, M., K. Sucher and S. Long (Eds), Nutrition Therapy and Pathophysiology, 1st Edn., Belmont (USA): Thomson Brooks/Cole, pp: 843-879.
39. Lemire, J.M., 1992. Immunomodulatory role of 1,25-dihydroxyvitamin D3. J. Cell. Biochem., 49: 26-31.
40. Liao, K., L. Alfredsson and E. Karlson, 2009. Environmental influences on risk for rheumatoid arthritis. Curr. Opin. Rheumatol., 21: 279-283.
41. Linker-Israeli, M., E. Elstner, J.R. Klinenberg, D.J. Wallace and H.P. Koeffler, 2001. Vitamin D(3) and its synthetic analogs inhibit the spontaneous in vitro immunoglobulin production by SLE-derived PBMC. Clin. Immunol., 99: 82-93.
42. Lipsky, P., 2005. Rheumatoid arthritis. In: Kasper, D., E. Braunwald, A. Fauci, S. Hausner, D. Longo and J. Jameson (Eds), Harrison's Principles of Internal Medicine, 16th Edn., New York: McGraw-Hill, pp: 2268-2278.
43. Little, C. and T. Parsons, 2000. Herbal therapy for treating rheumatoid arthritis. Cochrane Database of Systematic; Reviews. 4: CD002948.
44. Maalej, A., E. Petit-Teixeira, L. Michou, A. Rebai, F. Cornelis and H. Ayadi, 2005. Association study of VDR gene with rheumatoid arthritis in the French population. Genes Immunol., 6: 707-711.
45. Mahon, B.D., A. Wittke, V. Weaver and M. Cantorna, 2003. The targets of vitamin D depend on the differentiation and activation status of CD4 positive T cells. J. Cell. Biochem., 89: 922-932.
46. Martin, R., 1998. The role of nutrition and diet in rheumatoid arthritis. Proc. Nutr. Soc., 57: 231-234.
47. Mathieu, C., E. Van Etten, C. Gysemans, B. Decallonne, S. Kato, J. Laureys, J. Depovere, D. Valckx, A. Verstuyf and R. Bouillon, 2001. In vitro and in vivo analysis of the immune system of vitamin D receptor knockout mice. J. Bone Miner. Res., 16: 2057-2065.
48. Mattner, F., S. Smiroldo, F. Galbiati, M. Muller, P. Di Lucia, P.L. Poliani, G. Martino, P. Panina-Bordignon and L. Adorini, 2000. Inhibition of Th1 development and treatment of chronic-relapsing experimental allergic encephalomyelitis by a non-hypercalcemic analogue of 1,25-dihydroxyvitamin D(3). Eur. J. Immunol., 30: 498-508.
49. Merlino, L.A., J. Curtis, T.R. Mikuls, J. Cerhan, L. Criswell and K. Saag, 2004. Vitamin D intake is inversely associated with rheumatoid arthritis: Results from the Iowa Women's Health Study. Arth Rheuma., 50: 72-77.
50. NIH (National Institutes of Health), 2008. Dietary Supplement Fact Sheet: Vitamin D. Maryland, USA.
51. O'Dell, J., 2004. Therapeutic strategies for rheumatoid arthritis. The New Eng. J. Med., 350: 2591-602.
52. Padyukov, L., C. Silva, P. Stolt, L. Alfredsson and L. Klareskog, 2004. A gene-environment interaction between smoking and shared epitope genes in HLA-DR provides a high risk of seropositive rheumatoid arthritis. Arth. Rheum., 50: 3085-3092.
53. Pattison, D., D. Symmons and A. Young, 2004. Does diet have a role in the etiology of rheumatoid arthritis? Proc. Nutr. Soc., 63: 137-143.
54. Plenge, R.M., M. Seielstad and L. Padyukov, 2007. TRAF1-C5 as a risk locus for rheumatoid arthritis-a genome wide study. The New Eng. J. Med., 357: 1199-209.
55. Rejnmark, L., M.E. Jorgensen and M.B. Pedersen, 2004. Vitamin D insufficiency in Greenlanders on a westernized fare: Ethnic differences in calcitropic hormones between Greenlanders and Danes. Calci. Tiss. Int., 74: 255-263.
56. Rennie, K., J. Hughes and S. Jebb, 2003. Nutritional management of rheumatoid arthritis: A review of the evidence. J. Hum. Nutr. Diet., 16: 97-109.
57. Rizzo, D., 2005. Disorders of skeletal function: Rheumatic disorders. In: Porth, C. (Ed), Pathophysiology: Concepts of Altered Health Status, 7th Edn., PA: Lippincott Williams and Wilkins, pp: 1417-1440.
58. SACN (Scientific Advisory Committee on Nutrition), 2007. Update on Vitamin D. London.
59. Stockinger, B., 2007. Th17 cells: An orphan with influence 4. Immunol. Cell Biol., 85: 83-84.
60. Tao, X., J. Younger, F.Z. Fan, B. Wang and P.E. Lipsky, 2002. Benefit of an extract of Tripterygium wilfordii Hook F in patients with rheumatoid arthritis: A double-blind, placebo-controlled study. Arth. Rheu., 46: 1735-1743.
61. Turesson, C., W. O'Fallon, C. Crowson, S. Gabriel and E. Matteson, 2003. Extra-articular disease manifestations in rheumatoid arthritis: Incidence trends and risk factors over 46 years. Anna. Rheum. Dis., 62: 722-727.
62. Turhanoglu, A., H. Guler, Z. Yonden, F. Aslan, A. Mansurolgu and C. Ozer, 2010. The relationship between vitamin D and disease activity and functional health status in rheumatoid arthritis. Rhemat. Int., 1: 1393-1396.
63. U.S. Department of Health and Human Services, 2001. Prevalence of Disabilities and associated health conditions among adults-United States, 1999. MMWR Morb. Mortal Wkly. Report, 50: 120-125.
64. Van, E.E. and C. Mathieu, 2005. Immunoregulation by 1,25-dihydroxyvitamin D3: Basic concepts. J. Ster. Biochem. Mol. Biol., 97: 93-101.
65. Vital, E. and P. Emery, 2005. Advances in the treatment of early rheumatoid arthritis. Am. Fam. Physician, 72: 1002-1004.
66. Volker, D., P. Fitzgerald, G. Major and M. Garg, 2000. Efficacy of fish oil concentrates in the treatment of rheumatoid arthritis. J. Rheu., 27: 2343-2346.